J&J (JNJ), CR Bard (BCR) Ordered to Study Injuries from Vaginal Implants -Bloomberg
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Join SI Premium – FREE
Traders should watch shares of J&J (NYSE: JNJ) and CR Bard (NYSE: BCR) as Bloomberg is reporting the companies have been ordered to study injuries from vaginal implants. The FDA order is for a 3-year study including 33 device companies.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- FDA grants accelerated approval to Ultragenyx gene therapy for GSDIa
- FDA grants fast track status to Rein Therapeutics drug for lung fibrosis
Create E-mail Alert Related Categories
FDA, Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
